regulating MCU activity. Here, we highlight the contribution of MCU activity to vascular endothelial cell (EC) function. Besides the ionic and oxidant regulation, ECs are continuously exposed to haemodynamic forces (either pulsatile or oscillatory fluid mechanical shear stresses, depending on the precise EC location within the arteries). Thus, we also propose an EC mechanotransduction-mediated regulation of MCU activity in the context of vascular physiology and atherosclerotic vascular disease.
Introduction
The endothelium is a cellophane-like membrane lining the circulatory system and its major functions are regulation of vascular tone and vessel wall permeability. Endothelial cell (EC) dysfunction has been implicated in the early stages of many cardiovascular diseases, which renders the modulation of EC functions a key therapeutic target [1] [2] [3] . Under normal conditions, EC functions depend on changes in the intracellular calcium concentration ([Ca 2þ ] i ). The Ca 2þ concentration in extracellular biological fluids is in the range of 1.6-2 mM, whereas, within cells, Ca 2þ is bound to phospholipids, proteins and nucleic acids or is sequestered in organelles, and thus only 0.1% of the total Ca 2þ content is free in the cytosol. Consequently, [Ca 2þ ] i is kept at approximately 100 nM to regulate cellular processes that function over a wide dynamic range. In most cells, increases in [Ca 2þ ] i are transient and oscillatory [4] and the frequency of oscillation (temporal [Ca 2þ ] i signature) is differentially decoded as cellular signal [5] . At any time, the spatio-temporal complexity in the regulation of [Ca 2þ ] i is determined by a balance between the interplay of multiple counteracting processes divided into 'on' and 'off' mechanisms. The 'on' reaction results in generation of the [Ca 2þ ] i rise due to Ca 2þ influx from the extracellular medium and Ca 2þ release from intracellular stores, such as the endoplasmic reticulum (ER) in non-excitable cells. The 'off' reaction removes intracellular Ca 2þ by the combined action of pumps, buffers and exchangers. One important intracellular organelle associated with Ca 2þ handling is the mitochondrion [6, 7] . Although & 2017 The Author(s) Published by the Royal Society. All rights reserved.
other compartments such as the ER, lysosomes, Golgi apparatus and endosomes are recognized as Ca 2þ stores [7] [8] [9] , the mitochondria remain highly specialized in this context because of their sponge-like retentive capacity with regard to Ca 2þ .
In ECs, the mitochondria account for 25% of the cell's Ca 2þ storage. It has long been ascertained that mitochondrial content in ECs is modest (endothelial mitochondria occupy 2-6% of the cytoplasmic volume) compared with cardiac myocytes (32% of the cytoplasmic volume) and other cell types, as the energy requirements in ECs are relatively low and glycolysis is the major source of ATP production. In vitro and in vivo studies have shown that, apart from the well-known role of mitochondria in bioenergetics, they also play a prominent role in signalling cellular responses to environmental cues [10] [11] [12] . Two such important modes of signalling are their regulated production of mitochondrial reactive oxygen species (mROS) and their service as Ca 2þ sinks. Mitochondrial Ca 2þ uptake and mROS generation are interdependent phenomena and contribute to cell function in a 'mutual crosstalk', with mitochondrial Ca 2þ concentration ([Ca 2þ ] m ) representing the key to deciphering mROS signals [13] .
Mitochondria have a large negative membrane potential of 180 mV that facilitates flooding of mitochondria by Ca 2þ from the cytosolic milieu. During evolution, cells acquired sophisticated mitochondrial Ca 2þ transport machineries that control Ca 2þ entry to the mitochondrial matrix and Ca 2þ exit/redistribution for proper cell function. The mitochondrial Ca 2þ uptake system is a heterogeneous protein complex with the molecular identity mixed and matched with the mitochondrial Ca 2þ uniporter (MCU) as the core component [14, 15] . The MCU is regulated by an array of proteins including mitochondrial Ca 2þ uptake 1 (MICU1), 2 (MICU2), 3 (MICU3), essential MCU regulator (EMRE), MCU regulating protein 1 (MCUR1) and MCU dominant negative beta subunit (MCUb) (see §2 for a complete description) [16] [17] [18] [19] [20] [21] [22] [23] [24] . Besides protein regulation (positive by MCUR1 and EMRE [19, 23] and negative by MICU1 [22] ), recent studies from our group and others demonstrated a regulation of mitochondrial Ca 2þ uptake by ions and redox signalling. In this review, we summarize these regulatory mechanisms of MCU activity and suggest a potential therapeutic utility in controlling endothelial MCU activity during vascular ( patho)physiology. We also introduce a novel hypothesis that spatial regulation of MCU activity by local haemodynamic forces (via their effect on ion and redox signalling) in human arteries may, at least in part, explain the focal nature of atherosclerotic vascular disease. Since atherosclerotic vascular disease continues to be the major cause of death in developed nations [25] and EC dysfunction plays a causative role in disease initiation [26, 27] , this review aims to position the MCU as a potential critical target for intervention against atherosclerosis.
Ionic regulation of mitochondrial Ca 2þ uptake
The MCU contains two transmembrane (TM) domains with coiled-coil regions positioned before and after these domains. Topologically, both the N-and C-terminal regions reside in the matrix constituting a majority of the protein [28] . The regulation of the MCU pore is complex as evidenced by the numerous protein regulators which have been identified. MCUb is a homologue of MCU sharing 50% sequence similarity, but no ability to constitute a Ca 2þ -permeable channel despite the presence of similar TM domains to those found in the MCU. These MCUb TM domains contain two noteworthy amino acid substitutions (R251Q and D256V) compared with the MCU, which may be related to the dominant negative inhibition of MCU activity after interactions with MCUb [20] . 
(c) Figure 1 . Structural mechanisms of MCU regulation. (a) Crystal structure of human MICU1 residues 108-442 in the Ca 2þ -bound state. The conformation and orientation of the two EF-hand domains (yellow ribbon diagrams; EF1 (residues 219-315); EF2 (residues 374-442)) are shown relative to the two preceding intervening domains (ID1, green ribbon diagram (residues 108-218); ID2, blue ribbon diagram (residues 316-373)). Each EF-hand domain coordinates a single Ca 2þ atom (orange spheres). (b) All-atom structural alignment of the MICU1 ID1 domain in the presence (green ribbon) and absence (grey ribbon) of Ca 2þ . (c) All-atom structural alignment of the MICU1 ID2 domain in the presence (blue ribbon) and absence (grey ribbon) of Ca 2þ . ID1 and ID2 adopt similar structures with the EF-hand domains in either an open or a closed conformation. (d) NMR-and transmission electron microscopy-driven model of the Caenorhabditis elegans C-terminal domain residues 166-318. The inner pore is made up of TM2 (magenta ribbons; residues 244-260) and is surrounded by TM1 (light blue ribbons; residues 215-234). The DXXE motif (dashed black circle) links TM1 and TM2. The Asp240 (red space fill) and Glu243 (orange space fill) residues which bind Mn 2þ cooperatively are indicated within the DXXE motif. The outer and inner coiled-coil bundles (CC1, brown ribbons (residues [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] alignment of ID1/2 domains when EF1/2 are in the Ca 2þ -loaded and -depleted states show only minor structural differences ( figure 1b,c) Although a high-resolution structure of the pore-forming and coiled-coil regions of human MCU is currently unavailable, a nuclear magnetic resonance (NMR) spectroscopy-and transmission electron microscopy-driven pentameric model of Caenorhabditis elegans MCU with a deleted N-terminal domain has been constructed [62] . This structure shows that the second TM domain is positioned to line the pore of the channel with a short DXXE motif contributed by each subunit lining the entrance to the pore (figure 1d). The DXXE motif links the first and second TM domains. While the Glu is positioned deeper in the pore, the Asp is more solvent exposed, and mutating either of these acidic residues abrogates MCU channel activity [14] . figure 1e ). The shorter a2-helix sits as a cap on the overall globular fold and is arranged approximately perpendicular to the central a1-helix. Interestingly, the extended loop 2, which connects the b1-and b2-strands and contains the S92 and C97 residues previously found to regulate channel activity by phosphorylation [66,67] and S-glutathionylation (SSG) [65] , respectively, also contains a salt bridge which stabilizes this functionally important loop (figure 1f ). The salt bridge is not present in all crystal forms, suggesting that local environmental conditions, including ionic strength, can modulate the structure and stability of the loop and, thus, the post-translational modifications which regulate channel activity.
The surface electrostatic potential of the MCU N-terminal domain forms two negatively charged acidic and two positively charged basic patches. The largest acidic patch is near the C-terminal region of the domain and is primarily constituted by D131, D142, D147, D148 and D166 residues (figure 1g). These acidic residues are conserved among vertebrate MCU homologues, suggesting an important role affiliated with the surface exposure. [84] ) and increases the mROS levels (figure 2a) [13, 85] . Mitochondrial O 2 Á2 production takes place at ETC complexes I, II and III (mainly I and III; figure 2a) [86, 87] . [92] , whereas reactive Cys oxidation in Orai1/2 channels inhibits Ca 2þ entry [94, 95] . mROS are involved in a plethora of signalling pathways, such as nuclear factor-kB (NF-kB)-and tumour necrosis factor-a (TNF-a)-induced signalling, leading to expression of cell adhesion molecules and cell dysfunction, but also activation of survival mechanisms [96] [97] [98] [99] [100] [101] [102] . ROS were found to exert their effect via SSG of regulatory Cys within NF-kB (inhibited by SSG) and the TNF receptor Fas (activated by SSG) [103] [104] [105] . However, the role of SSG of proteins within the mitochondrial compartment in the pathogenesis of cardiovascular disease has not been defined. 
Regulation of mitochondrial Ca 2þ transport by mechanical forces
Mechanical forces are known factors in regulating every organ system in the human body, but are crucial in the development and physiology of the circulatory system [115, 116] . Fluid [117] [118] [119] [120] [121] [122] . Atherosclerotic vascular disease continues to be the major cause of death in developed nations [25] . Though influenced by systemic risk factors (hyperlipidaemia, hypertension, diabetes, smoking), atherosclerotic plaques develop preferentially at the outer walls of bifurcations, the inner walls of curvatures and downstream of a stenosis in the carotid, coronary, aortic, renal, iliac, femoral and other arteries [123, 124] . It is well accepted that modulation of the vascular EC phenotype by the local haemodynamic forces in those regions contributes to the geometrically focal nature of the disease [26, [125] [126] [127] . ECs in arteries and arterioles are continuously exposed to three types of haemodynamic stress (force/surface area): normal stress (due to hydrostatic pressure), tensile stress (due to transmural pressure difference) and shear stress (the frictional force exerted by blood flowing over the EC luminal surface) [128, 129] . As EC dysfunction is a key and early factor in atherogenesis, and ECs, due to their unique location, experience complex blood flow/shear stress profiles, a lot of research has focused on the effects of shear stress on EC physiology and pathology. Wall shear stress is the product of blood viscosity and the velocity gradient (slope of the velocity vector in a direction normal to the wall) on the EC luminal surface. For most of the arterial circulation, local wall shear stress can be considered proportional to the volumetric flow rate and inversely proportional to the cube power of the internal radius at each axial position along the blood vessel [130] [131] [132] . Using different imaging modalities to measure flow rates and internal diameters, the wall shear stress in straight portions of the arterial vascular network was estimated to vary between 1 and 7 Pa (10-70 dynes cm
22
). Those regions, which include locations preceding and following arterial bifurcations as well as the inner walls of flow dividers, are spared from atherosclerotic disease. Flow in those regions is undisturbed (characterized by parallel streamlines), laminar (Reynolds number less than 2100), unsteady (due to the cardiac cycle) and unidirectional; the wall shear stress is called pulsatile (PS) and has a relatively high mean value (figure 3a) [119, 125, 133] . In regions susceptible to disease, such as the outer walls of bifurcations, the local flow is disturbed and reverses during the systole phase of the cardiac cycle (within a flow recirculation zone with high temporal and spatial shear stress gradients), but it is still laminar; the wall shear stress is called oscillatory (OS), has a mean close to zero and varies between +0.6 Pa (6 dynes cm 22 ) (figure 3a) [119, 125, 133] . Histology and digital image analysis of microparticle flow in post-mortem arteries, non-invasive (magnetic resonance phase velocity mapping) and invasive imaging modalities (coronary angiography, intravascular ultrasound), together with computational fluid dynamics, have verified the spatial correlation between OS and atherosclerosis initiation and progression in animals and humans [120, 124, 134, 135] .
In order to understand the EC phenotypes due to exposure to different shear stress profiles, many groups have subjected cultured ECs from different species and vascular beds (or ex vivo arteries) to controlled flow conditions using perfusion chambers/systems or cone-and-plate viscometers followed by biochemical analysis at both the gene and protein levels [126, [136] [137] [138] [139] [140] . With few exceptions, most of those studies approximated PS and OS profiles as sinusoidal waves of fixed amplitude and period (figure 3b). For corresponding controls, cultured ECs were either exposed to undisturbed laminar steady shear stress (SS) at a value equal to the PS time-average or were left static (figure 3b). For verification of findings in vivo, the endothelium was isolated from regions in animal arteries known to be exposed to either PS or OS, and analysed for differential gene expression (mRNA, miRNA), and these databases drove further in vitro experimentation on upstream intracellular signalling pathways and downstream cell behaviour [127, 141, 142] . Changing arterial flow in animals by creating a stenosis through partial ligation (OS develops downstream) established the causal relationship between OS and atherogenesis [143] . In vitro studies showed the existence of metrics of PS and OS, besides the main ones (mean value, amplitude and period), such as shear stress angular direction, harmonic frequencies and oscillatory shear index, that are also sensed by ECs [144] [145] [146] ; in this review, we will refer to PS and OS based solely on their main metrics. Overall, both in vivo and in vitro studies verified that OS induces EC inflammation and dysfunction, which, in the presence of additional systemic risk factors, primes the OS-exposed arterial regions for disease initiation. It is noteworthy that the detrimental effect of OS is not purely mechanical; prolonged residence time of cytokines and other chemicals released by ECs and trapped blood cells in the flow recirculation zone contributes to the EC dysfunction.
PS (or SS) is known to decrease the EC proliferation rate and extent of apoptosis (the latter, following EC exposure to a stimulus that causes oxidative stress), rendering the endothelium 'atheroresistant', whereas OS does the opposite ('atherosusceptible' endothelium) [147] [148] [149] [150] . The atheroprotective effect of PS (or SS) is, to a large extent, due to shear-induced expression and activation of endothelial nitric oxide synthase (eNOS) that produces the vasodilator NO (figure 3c) [151] [152] [153] [154] . By contrast, eNOS expression was decreased under OS in vivo, compared with PS, and in vitro, compared with static controls (figure 3d) [153, 155, 156] . In agreement with that, isolated arterioles from animals/humans showed NO-dependent dilation under PS or SS; OS did not induce dilation [157, 158] . PS (or SS) was found to trigger EC secretion of ATP causing autocrine/paracrine activation of surface purinergic receptors (G q /G 11 protein-coupled P2Y 2 Rs), activation of PLC, generation of IP 3 The pro-inflammatory signalling pathways underlying atherogenesis, including c-Jun N-terminal kinase (JNK)/the family of mitogen-activated protein kinases (MAPKs) and the transcription factors NF-kB and activator protein-1 (AP-1), are redox sensitive [181] . OS was found to cause a sustained increase in O 2 Á2 production/ROS levels, whereas PS (or SS)
induced an increase upon the onset of flow, but, after the first couple of hours, the increase in ROS was compensated by upregulation of antioxidant defences, such as haem oxygenase-1 (HO-1) and NADPH quinone oxidoreductase 1 (NQO1), under the control of nuclear factor erythroid 2-related factor 2 (Nrf2) [153, [182] [183] [184] [185] [186] . NADPH oxidases (NOXs), xanthine oxidase, mitochondria and uncoupled eNOS are the main sources of cytosolic ROS in ECs [187] . PS (or SS) downregulated NOX4 expression; OS upregulated NOX1 and NOX2 expression in parallel with xanthine oxidase levels, with mixed results regarding the OS effects on NOX4 (figure 3c,d) [153, 188] . NOX1-derived ROS, in particular, were responsible for activation of NF-kB and upregulation of intercellular adhesion molecule-1 (ICAM-1) in OS-exposed ECs in vitro and in vivo [188] . Shear-induced ROS are expected to play a key role in 3c,d ) [13, 190] . Any O 2 Á2 in the cytosol/organelles that escaped antioxidant defences is consumed by a diffusion-limited reaction with NO to form the reactive nitrogen species (RNS) peroxynitrite (ONOO 2 ), thus lowering the bioavailable NO levels (ONOO 2 can also uncouple eNOS) and promoting atherosclerosis [191, 192] . Either OS-exposed ECs in vitro or atheroprone regions in vivo had increased levels of nitrotyrosine, the footprint of ONOO 2 formation, compared with PS-exposed ECs and atheroresistant regions, respectively (due to increased O 2 Á2 production and despite decreased NO generation under OS) [193] .
Á2
/ROS levels; the effect was attenuated when SS was performed at lower than atmospheric (closer to arterial) O 2 levels [194, 195] . Interestingly, NOX-derived O 2
/ROS were found to either activate or inactivate eNOS: under SS (and one might assume the same for PS), activated NOX2/p47phox and resultant ROS were responsible for eNOS activation, whereas, under OS, ROS from activated NOX1/NOXO1 caused eNOS uncoupling leading to eNOS-derived O 2
/ROS and a concomitant decrease in NO production/bioavailable levels ( figure 3c,d ) [196] . Based on the higher levels of mROS/cytosolic ROS in OS-exposed ECs compared with PS (or SS)- figure 3c,d ), which may be the reason behind the OS-induced EC inflammation and decreased cell resistance to apoptosis.
Mitochondrial Ca 2þ uniporter: a potential therapeutic target in vascular diseases
The speculation regarding altered MCU activity in the endothelium of atheroprone regions, compared with activation in atheroprotective ones, is in agreement with the oxidative stress and inflammation encountered in those locations. [197] showed that human aortic ECs (HAECs) treated with the proinflammatory lipid lysophosphatidylcholine increased their mROS due to enhanced MCU activation; both were attenuated in the presence of the mROS scavenger mitoTEMPO. MitoTEMPO also suppressed EC activation and monocyte recruitment in the aorta of ApoE 2/2 mice fed with a high-fat diet [197] . Although this study did not examine specific aortic locations, the beneficial effect of the drug would be apparent in locations that experience OS. Decreasing mitochondrial Ca 2þ entry in vitro can also be done by knocking down proteins involved in ER-mitochondria contact sites and, thus, increasing the MAM width. Although this method cannot be translated to clinical settings, nevertheless it was shown that it protects cultured cells from oxidative stressinduced apoptosis [198] . One of the reasons why graded inhibition of MCU activity may be able to maintain EC health in OS-exposed regions is its potential impact on autophagy. Autophagy is a critical homeostatic mechanism in rsif.royalsocietypublishing.org J. R. Soc. Interface 14: 20170672 cardiovascular health [199] [200] [201] . Functional autophagy was shown to be a prerequisite for the SS-induced increase in NO production [202, 203] . Dysfunctional autophagy occurs when autophagy induction (autophagosome formation) becomes highly activated and, as a result, the autophagic flux (rate of autophagosome-lysosome fusion and degradation of autophagosomal cargo) slows down ('impaired' flux) leading to inadequate removal of dysfunctional mitochondria and a tonic increase in oxidative stress. Li et al. [204] showed that OS exposure increases the induction of autophagy, but decreases the autophagic flux in cultured HAECs (whereas PS maintains autophagy at levels comparable to static controls); both the increased induction and decreased flux under OS were mediated by JNK activation and elevated mROS. The impaired EC autophagic flux was verified in OS-exposed regions of rabbit aortas [204] . Graded inhibition of MCU activation in OS-exposed regions will reduce mROS, which, by lowering autophagy induction, should allow for, at least, partial normalization of the impaired flux, in agreement with a recent review [205] . In support of the importance of a functional autophagic flux in EC health, it was recently shown that SS upregulates the transcription factor EB (TFEB), master regulator of autophagic flux and lysosomal biogenesis, and that transgenic mice with EC-specific TFEB expression exhibit reduced leucocyte recruitment to ECs and decreased development of atherosclerosis [206] . Since mitochondrial ion homeostasis plays a major role in endothelial function, we put forward a hypothesis that perturbation of mitochondrial Ca 2þ homeostasis could lead to several vascular pathological conditions. 
